{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:43:09Z","timestamp":1790095389462,"version":"4.0.1"},"reference-count":40,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths globally. Current treatment options including chemotherapy and targeted therapies face challenges such as resistance and toxicity. Cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase 5 (PDE5) has emerged as a promising target for CRC therapy due to its role in regulating cellular processes like proliferation and apoptosis. This study focuses on the in silico design of a novel PDE5 inhibitor MS01 derived from the lead compound exisulind which has shown apoptotic effects but failed due to hepatotoxicity. Using Schr\u00f6dinger\u2019s Induced Fit Docking (IFD) and molecular dynamic simulations, MS01 was designed to enhance binding affinity and reduce toxicity. The docking studies showed that MS01 exhibits stronger interactions with key PDE5 residues, particularly Gln817 and Phe820. ADMET predictions indicate favorable pharmacokinetic profiles, with reduced risk of drug\u2013drug interactions and improved bioavailability. Toxicity assessments revealed that MS01 and its analogs have moderate toxicity, with MS20 and MS21 demonstrating lower hepatotoxicity compared to exisulind. These findings suggest that MS01 has the potential to be a more effective and safer PDE5 inhibitor for CRC treatment pending further experimental validation.<\/jats:p>","DOI":"10.3390\/ijms26051937","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:47:17Z","timestamp":1740379637000},"page":"1937","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Rational Design and Optimization of Novel PDE5 Inhibitors for Targeted Colorectal Cancer Therapy: An In Silico Approach"],"prefix":"10.3390","volume":"26","author":[{"given":"Samson Marvellous","family":"Oladeji","sequence":"first","affiliation":[{"name":"Department of Chemistry, Purdue University, West Lafayette, IN 47907, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah Ngozi","family":"Conteh","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Ilorin, P.M.B, Ilorin 1515, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9355-7768","authenticated-orcid":false,"given":"Lukman Abidemi","family":"Bello","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Purdue University, West Lafayette, IN 47907, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1349-9966","authenticated-orcid":false,"given":"Abayomi Emmanuel","family":"Adegboyega","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Structural and Computational Biology, Purdue University, West Lafayette, IN 47907, USA"},{"name":"Jaris Computational Biology Centre, Bioinformatics Unit, Jos 930241, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6027-4543","authenticated-orcid":false,"given":"Oluwatosin Sarah","family":"Shokunbi","sequence":"additional","affiliation":[{"name":"Department of Basic Sciences, Babcock University, School of Science and Technology, Babcock University, Ilishan-Remo 121003, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA A Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal Cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer Statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA A Cancer J. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41392-020-0116-z","article-title":"Comprehensive Review of Targeted Therapy for Colorectal Cancer","volume":"5","author":"Xie","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2174\/1568009617666170209095143","article-title":"Metastatic Colorectal Cancer: Role of Target Therapies and Future Perspectives","volume":"18","author":"Nappi","year":"2018","journal-title":"Curr. Cancer Drug Targets CCDT"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/14737159.2020.1782194","article-title":"Incorporating Traditional and Emerging Biomarkers in the Clinical Management of Metastatic Colorectal Cancer: An Update","volume":"20","author":"Baraibar","year":"2020","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_7","first-page":"1520","article-title":"Recognizing and Managing Side Effects Associated with Novel Targeted Therapies","volume":"20","author":"Jeanne","year":"2006","journal-title":"Oncology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41573-019-0033-4","article-title":"Therapeutic Targeting of 3\u2032,5\u2032-Cyclic Nucleotide Phosphodiesterases: Inhibition and Beyond","volume":"18","author":"Baillie","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/cancers6010436","article-title":"The Role of Cyclic Nucleotide Signaling Pathways in Cancer: Targets for Prevention and Treatment","volume":"6","author":"Fajardo","year":"2014","journal-title":"Cancers"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1038\/sj.ijir.3901207","article-title":"Tissue Expression, Distribution, and Regulation of PDE5","volume":"16","author":"Lin","year":"2004","journal-title":"Int. J. Impot. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pharmthera.2014.10.003","article-title":"PDE5 Inhibitors as Therapeutics for Heart Disease, Diabetes and Cancer","volume":"147","author":"Das","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Ahmed, W.S., Geethakumari, A.M., and Biswas, K.H. (2021). Phosphodiesterase 5 (PDE5): Structure-Function Regulation and Therapeutic Applications of Inhibitors. Biomed. Pharmacother., 134.","DOI":"10.1016\/j.biopha.2020.111128"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Haider, M., Elsherbeny, A., Pittal\u00e0, V., Fallica, A.N., Alghamdi, M.A., and Greish, K. (2021). The Potential Role of Sildenafil in Cancer Management through EPR Augmentation. J. Pers. Med., 11.","DOI":"10.20944\/preprints202104.0679.v1"},{"key":"ref_14","first-page":"3311","article-title":"Sildenafil Inhibits the Growth of Human Colorectal Cancer in Vitro and in Vivo","volume":"5","author":"Mei","year":"2015","journal-title":"Am. J. Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1158\/1940-6207.CAPR-17-0015","article-title":"Sildenafil Suppresses Inflammation-Driven Colorectal Cancer in Mice","volume":"10","author":"Islam","year":"2017","journal-title":"Cancer Prev. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1517\/13543784.10.10.1875","article-title":"Exisulind, a Selective Apoptotic Antineoplastic Drug","volume":"10","author":"Goluboff","year":"2001","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_17","first-page":"3338","article-title":"Exisulind Induction of Apoptosis Involves Guanosine 3\u2032,5\u2032-Cyclic Monophosphate Phosphodiesterase Inhibition, Protein Kinase G Activation, and Attenuated Beta-Catenin","volume":"60","author":"Thompson","year":"2000","journal-title":"Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0006-2952(02)01345-X","article-title":"Pro-Apoptotic Actions of Exisulind and CP461 in SW480 Colon Tumor Cells Involve \u03b2-Catenin and Cyclin D1 down-Regulation","volume":"64","author":"Li","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Adis Editorial (2004). Exisulind. Drugs R D, 5, 220\u2013226.","DOI":"10.2165\/00126839-200405040-00007"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1126\/science.288.5472.1822","article-title":"Atomic Structure of PDE4: Insights into Phosphodiesterase Mechanism and Specificity","volume":"288","author":"Xu","year":"2000","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.molcel.2004.07.005","article-title":"A Glutamine Switch Mechanism for Nucleotide Selectivity by Phosphodiesterases","volume":"15","author":"Zhang","year":"2004","journal-title":"Mol. Cell"},{"key":"ref_22","unstructured":"(2024, August 18). Minimizing the DILI Potential of Carboxylic Acid-Containing Drugs: A Perspective|Medicinal Chemistry Research. Available online: https:\/\/link.springer.com\/article\/10.1007\/s00044-023-03140-9."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Dhiman, P., Arora, N., Thanikachalam, P.V., and Monga, V. (2019). Recent Advances in the Synthetic and Medicinal Perspective of Quinolones: A Review. Bioorg. Chem., 92.","DOI":"10.1016\/j.bioorg.2019.103291"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.clinmicnews.2021.06.001","article-title":"The Fluoroquinolones: An Update for the Clinical Microbiologist","volume":"43","author":"Maris","year":"2021","journal-title":"Clin. Microbiol. Newsl."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1021\/acs.jmedchem.6b01807","article-title":"The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization","volume":"60","author":"Pennington","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1126\/science.adj5331","article-title":"Aromatic Nitrogen Scanning by Ipso-Selective Nitrene Internalization","volume":"381","author":"Pearson","year":"2023","journal-title":"Science"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1021\/jm50003a001","article-title":"The Trifluoromethyl Group in Medical Chemistry","volume":"1","author":"Yale","year":"1959","journal-title":"J. Med. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1158\/1940-6207.CAPR-11-0559","article-title":"A Novel Sulindac Derivative That Potently Suppresses Colon Tumor Cell Growth by Inhibiting cGMP Phosphodiesterase and \u03b2-Catenin Transcriptional Activity","volume":"5","author":"Whitt","year":"2012","journal-title":"Cancer Prev. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1158\/1940-6207.CAPR-09-0001","article-title":"A Novel Sulindac Derivative That Does Not Inhibit Cyclooxygenases but Potently Inhibits Colon Tumor Cell Growth and Induces Apoptosis with Antitumor Activity","volume":"2","author":"Piazza","year":"2009","journal-title":"Cancer Prev. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/jps.21494","article-title":"Calculation of Molecular Lipophilicity: State-of-the-Art and Comparison of Log P Methods on More than 96,000 Compounds","volume":"98","author":"Mannhold","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Daina, A., Michielin, O., and Zoete, V. (2017). SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules. Sci. Rep., 7.","DOI":"10.1038\/srep42717"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/092986709787002817","article-title":"Topological Polar Surface Area: A Useful Descriptor in 2D-QSAR","volume":"16","author":"Prasanna","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.drudis.2019.10.014","article-title":"A Drug-Likeness Toolbox Facilitates ADMET Study in Drug Discovery","volume":"25","author":"Jia","year":"2020","journal-title":"Drug Discov. Today"},{"key":"ref_34","unstructured":"(2024, September 20). The Biochemistry of Drug Metabolism\u2014An Introduction\u2014Testa\u20142009\u2014Chemistry & Biodiversity\u2014Wiley Online Library. Available online: https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cbdv.200900022."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/wcms.52","article-title":"Understanding Drug-Likeness","volume":"1","author":"Ursu","year":"2011","journal-title":"WIREs Comput. Mol. Sci."},{"key":"ref_36","unstructured":"(2024, September 28). P-Glycoprotein Substrate Assessment in Drug Discovery: Application of Modeling to Bridge Differential Protein Expression Across In Vitro Tools\u2014ScienceDirect. Available online: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0022354920305153?via%3Dihub."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2012.09.019","article-title":"Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings","volume":"64","author":"Lipinski","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Zhao, M., Ma, J., Li, M., Zhang, Y., Jiang, B., Zhao, X., Huai, C., Shen, L., Zhang, N., and He, L. (2021). Cytochrome P450 Enzymes and Drug Metabolism in Humans. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222312808"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"W513","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0: A Webserver for the Prediction of Toxicity of Chemicals","volume":"52","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1021\/ct200133y","article-title":"Improved Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of pKa Values","volume":"7","author":"Olsson","year":"2011","journal-title":"J. Chem. Theory Comput."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/5\/1937\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:41:09Z","timestamp":1760028069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/5\/1937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["ijms26051937"],"URL":"https:\/\/doi.org\/10.3390\/ijms26051937","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,24]]}}}